Skip to main content

Table 1 Numbers of samples showing immunoreaction to ER-α, ER-β, AR, and DAX-1

From: DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status

  BBD (n = 14) CIS (n = 14) Infiltrative ductal carcinoma (n = 24) Infiltrative lobular carcinoma (n = 15)
Protein N C N C N C N C
ER-α 0 (0) 0 (0) 6 (42.86) 4 (28.57) 15 (62.5) 3 (12.5) 9 (60) 6 (40)
ER-β 0 (0) 0 (0) 0 (0) 4 (28.57) 0 (0) 9 (37.5) 0 (0) 9 (60)
AR 0 (0) 3 (21.4) 1 (7.15) 4 (28.57) 3 (12.5) 9 (37.5) 1 (6.66) 9 (60)
DAX-1 3 (21.42) 5 (35.72) 3 (21.43) 4 (28.57) 9 (37.5) 6 (25) 7 (46.66) 5 (33.33)
  1. Results in parentheses are percentages. AR, androgen receptor; BBD, benign breast diseases; C, cytoplasmic immunoreaction; CIS, in situ carcinomas; ER, estrogen receptor; N, nuclear immunostaining.
\